T h e purpose of this review is to summarize the evidence from more than 40 studies that naturally occurring variants of uncoupling proteins 1-3 (UCP1-3) have detectable physiological effects in humans. Although UCPl is known to influence mitochondrial proton leak in oitro and core body temperature in mice, genetic studies in humans have produced only weak evidence for association of naturally occurring variants with body-mass index (BMI); the best-reported Pvalue is 0.01. In contrast, current evidence is consistent with the hypothesis that UCP2 and 3 influence BMI, since the best reported P values are better: four studies report associations of 0.001 (2 studies) to 0.002 (1 study) and 0.005 (1 study) for a UCP2 insertion/ deletion variant, while the best P values for association of UCP3 with BMI are 0.003 (1 study) and 0.0037 (1 study). UCP2 and 3 are adjacent to each other on chromosome 11 and variants in each are in linkage disequilibrium. Thus, variants in UCP2 or 3 may influence results from association studies of variants in the other. Since UCP2 has a 
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Introduction
T h e roles of uncoupling proteins 1-3 (UCPl-3) in human physiology can be directly tested using association studies, which examine the hypothesis that naturally occurring variants in the expressed genes, their promoters or introns, influence traits such as body-mass index (BMI) or energy expenditure. No studies have yet tested the possibility that variants of UCP4 and 5 (brain mitochondrial carrier protein, BMCPl) influence human physiology. Genetic studies in humans can provide definitive proof about the physiological function of a gene, such as the demonstration that people with mutations of the leptin gene are obese. However, mutations that cause obesity inherited in a simple Mendelian fashion (dominant or diet interactions that result in associations apparent only for people eating a specific diet. For instance, population studies of the common variant of the nuclear receptor peroxisome proliferatoractivated receptor-? (PPARy Prol 2Ala) have produced conflicting results. As it is likely that the natural ligands for this receptor may include fatty acids, the effect of this common variant may be altered by the character of the diet, particularly the ratio of dietary polyunsaturated fat to saturated fat ( P : S ratio) [S] . 592 non-diabetic people were genotyped for the Prol 2Ala polymorphism [5].
There was no difference in fasting insulin concentration or BMI between Ala allele carriers and Pro homozygotes. A strong interaction was evident between the dietary P : S ratio and the Pro12Ala polymorphism for both BMI (P = 0.0038) and fasting insulin (P = 0.0097) [5]. T h e data suggest that when the dietary P: S ratio is low, the BMI in Ala carriers is greater than that in Pro homozygotes, but when the dietary ratio is high, the opposite is seen. Since UCP2 expression is affected by fatty acids [6] and by peroxisome proliferatoractivated receptors [7] , then analogous interactions may influence apparent association of UCP variants with phenotypes. (3) Genetic heterogeneity, which refers to the observation that different people may have the same phenotype caused by different biological mechanisms, may influence results of association studies. Genetic heterogeneity may especially influence studies performed on people from different ethnic groups, which may differ in allele frequencies for variants that are tested and also for other nearby alleles that may influence traits but which are unknown or untested. (4) Different studies each selectively test some of the many variants present in each UCP. Selective testing of genetic variants is particularly important since some variants may be associated with some traits while other variants in the same gene are not. (5) An additional difference between studies is that many are underpowered (too small to detect effects).
While genetics studies can be used to prove that a protein has a particular function, they are very inefficient at providing proof that a protein does not have a function. Why? No genetic studies have yet tested hypotheses about all phenotypes that can be measured in people. Thus new studies need to be conducted for each phenotype because each study collects limited phenotype data. For instance, there are no studies examining the role of UCP2 in immune response and insulin secretion, even though mouse-knockout and transgenic data suggest that UCP2 influences these traits. This is particularly important because there have been several examples of proteins where different variants produce diseases that had been given different names. For instance, missense mutations in lamin A/C (LMNA, a component of the nuclear envelope) have been identified among individuals with familial partial lipodystrophy [8] . Heterozygous mutations in the same gene have recently been identified in people with two other inherited diseases : the variant form of muscular dystrophy (MD) known as autosomal dominant EmeryDreifuss M D (EDMD-AD) and dilated cardiomyopathy and conduction-system disease (CMDl A). As LMNA is ubiquitously expressed, the finding of site-specific amino acid substitutions in three separate clinical entities, partial lipodystrophy, EDMD-AD and C M D l A, reveals that distinct functional domains of the LMNA protein are required for the maintenance and integrity of different cell types.
Genetic studies of uncoupling proteins have produced conflicting ambiguous evidence. However, these reports are generally consistent with the hypothesis that the UCPl homologues UCP2 and 3 influence body-weight homoeostasis. We
will separately examine studies of each UCP because only a very few investigators have analysed polymorphisms in both UCP2 and 3 and none have explored the possibility that UCPl interacts with UCP2 and 3. Studies that have searched for linkage of the UCP2/3 locus with body weight or diabetes phenotypes will be discussed separately, since linkage studies involve different principles than association studies.
Association studies of UCP I
Since 1996 15 association studies have examined variants of UCPl (Tables 1 and 2 ). These studies can be divided into several types: three studies of expressed sequence variants, three studies of promoter variants, six studies of gene x gene interactions with p-3 adrenergic receptor and two studies of a weight-loss or weight-gain x gene interaction. General features of each study are provided in Table 1 , including which variants were genotyped, the population examined and the best reported P values. Two studies that reported positive results for UCP2 and negative results for UCPl are included in Table 2 . Some patterns are apparent in these studies. All three studies of UCPl expressed sequence variants failed to find any association with BMI or other obesity phenotype, whereas one out of three studies of promoter sequence variants reported only weakly positive results for association with BMI (P < 0.06). None of the six gene x gene interaction studies (Tables 1   and 2 
UCP2 variants on human phenotypes in association studies
This We would like to provide some specific comments about one large group of studies that has produced results frequently discordant with other studies. Six studies from Denmark, two each for UCPl-3, have all reported negative results for association of UCP variants with BMI or adult weight gain, and are sometimes the only negative report for a polymorphism, as is the case for the UCP2 insertion/deletion variant. Thus there appears to be a systematic difference between this study population and the populations examined 783 by most other investigators. There are many possible explanations : there may be unique gene x environment interactions in this population that could produce unique results, or the Danish studies could be examining a distinct ethnic group, perhaps with a founder effect.
Although more than 40 studies have been published that investigate the roles of human UCPs, all of these studies together have barely begun to test the hypothesis that UCPl-3 may influence human physiology. While studies in mice suggest that UCP2 may influence a variety of traits, such as immune response and pancreatic insulin secretion, no studies have even examined the effect of UCP2 variants on these phenotypes in humans. Studies of UCPs will also need to be repeated to more completely examine enough of the variants present in each gene to identify common haplotypes in each of the UCPs. Identification of haplotypes will allow investigators to test the entire genes, including unknown and unexamined alleles. Furthermore, there are likely to be many complex gene x gene interactions and gene x environment interactions involving the UCPs, but these are mostly untested.
